Bengaluru, Karnataka, India | July 2026 — Syngene International Limited has appointed Sreenivasulu Bandaru as Head of Chemical Development, Small Molecule CDMO. In his new role, he will lead the company’s chemical development capabilities for its Small Molecule Contract Development and Manufacturing Organization (CDMO) business, driving innovation across process development, scale-up, and Chemistry, Manufacturing & Controls (CMC) to support global pharmaceutical clients.
Sreenivasulu brings over 24 years of experience in process research, medicinal chemistry, and pharmaceutical development. Prior to joining Syngene International, he spent nearly 19 years at Sai Life Sciences Ltd., most recently serving as Vice President – Global Head, Process Development (India & UK). During his tenure, he led global R&D teams, delivered more than 350 customer projects, and built collaborations with over 10 of the world’s leading pharmaceutical companies.
Earlier, he held successive leadership roles including Vice President – Head, Process Research & Development, Associate Vice President, Senior Director, Director, Associate Director, and Principal Scientist within the organisation. Before Sai Life Sciences, he served as Senior Research Scientist at Albany Molecular Research, building strong expertise in medicinal chemistry, route scouting, process optimisation, and end-to-end chemical development.
Sreenivasulu completed Post-Doctoral research in Organic Chemistry at the University of Illinois Urbana-Champaign and the University of Notre Dame. He also holds a Ph.D. in Organic Chemistry from the University of Hyderabad and a Master of Science (M.Sc.) in Chemistry from Osmania University.
With deep expertise spanning medicinal chemistry, process development, CMC, and global pharmaceutical R&D, Sreenivasulu is well positioned to strengthen Syngene’s Small Molecule CDMO capabilities and support the company’s continued growth as a leading global research, development, and manufacturing partner.
About Syngene International Limited
Syngene International Limited is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemicals sectors. With more than 6,000 scientists and over 2 million square feet of specialised discovery, development, and manufacturing facilities, Syngene partners with leading global organisations including Amgen, Baxter, Bristol Myers Squibb, GSK, Zoetis, and Merck KGaA. The company delivers world-class scientific expertise, secure research capabilities, and high-quality manufacturing solutions that help accelerate innovation and reduce time-to-market.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
